Previously published screens used conventional methods such as NF-κB reporter genes assays to test various chemical libraries in cancer cells or DNA strand exchange fluorescence resonance energy transfer to identify p65/RelA-specific inhibitors (Baudy et al., 2009; Shiroma et al., 2020). This evidence concerns the gene NFKB1 and cancer.